BrainScope

Country:
USA
Founding year:
2006

BrainScope is a neurotechnology company developing portable diagnostic systems that use EEG and clinical data to assess brain injury. The company focuses on objective evaluation of traumatic brain injury, including concussion and mild TBI, in time-sensitive clinical environments.

BrainScope’s platform combines front-end EEG acquisition with proprietary algorithms that analyze brain electrical activity alongside clinical inputs. The system generates rapid, standardized outputs intended to aid clinicians in determining injury severity and the need for further imaging or intervention.

BrainScope’s devices are deployed in emergency departments, urgent care, sports medicine, and military settings to support frontline brain injury assessment. The company positions its technology as a diagnostic decision-support tool that complements existing clinical workflows rather than a standalone imaging modality.

Tools and Infrastructure
Diagnostics
Decision Support

Neurofounders Insights

Modality:
EEG
Form Factor:
Headset/cap
Interface Depth:
Non-invasive
Indication:
Head injury
Target user:
Clinicians
Regulatory stage:
FDA approved (PMA)

Public

BrainScope holds the distinction of being one of the first FDA-approved AI/ML devices in neurology, with its EEG-based traumatic brain injury assessment demonstrating 99% sensitivity for intracranial hemorrhage detection and documented 50% reductions in unnecessary CT scans at major health systems. Its PMA-level regulatory status is a significant competitive moat in the point-of-care brain injury assessment segment.

Related companies

Articles featuring

BrainScope

No articles yet!

Press releases

No press releases published yet.